Biogen MS Drug Results Are 'Mildly Encouraging' In Eye Disease Test

 – April 14, 2015  –– 

Results from using Biogen's experimental nerve repair drug in a disease of the eye were "mildly encouraging," experts say, keeping alive the hope that the medicine might work in multiple sclerosis. The drug, known as Anti-LINGO-1, is promising because it is the first medicine to try to repair damaged nerves in diseases like MS. "This is the first time that there is anything that has really shown a result where there is repair of an existing nerve," says Aaron Miller, MD, an MS expert at the Icahn School of Medicine at Mount Sinai. This is evidence of such repair, although Miller notes that it is "relatively soft."

- Dr. Aaron Miller, Professor, Neurology, Icahn School of Medicine at Mount Sinai, Medical Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis

Learn more